info icon

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

C3_BONE_CARTILAGE_LIMBS_WIDE

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C40
  • Hospital discharge: ICD-9 170[4-5]|170[7-8]
  • Hospital discharge: ICD-8 170[4-5]|170[7-8]
  • Cause of death: ICD-10 C40
  • Cause of death: ICD-9 170[4-5]|170[7-8]
  • Cause of death: ICD-8 170[4-5]|170[7-8]
  • Cancer registry: Topography ICD-O-3 C40
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

411

4. Check minimum number of events

None

411

5. Include endpoints

None

411

6. Filter based on genotype QC (FinnGen only)

364

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 364 172 192
Unadjusted period prevalence (%) 0.08 0.06 0.09
Median age at first event (years) 52.44 52.22 52.64

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
377
Matched controls
3770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
135.4
211.8
107
11
H02AB02
ATC
dexamethasone; systemic
87.7
144.6
77
11
130
Kela drug reimbursment
Malignant tumour
+∞
131.1
118
*
A04AA01
ATC
ondansetron; systemic, rectal
20.6
80.1
64
37
JN4BD
NOMESCO Finland
Extensive body CT
12.2
66.8
73
73
A03FA01
ATC
metoclopramide; systemic, rectal
7.1
66.3
129
259
NF3AA
NOMESCO Finland
Femur X-ray examination
16.0
66.2
60
44
N02AA05
ATC
oxycodone; systemic
6.6
61.8
129
276
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
+∞
57.8
54
*
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
56.7
53
*
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
+∞
55.6
52
*
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
55.6
52
*
JN4AD
NOMESCO Finland
Body CT examination
9.1
53.3
72
95
TPX10
NOMESCO Finland
Implantation of vascular injection port
19.6
52.3
42
24
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
50.1
47
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
49.0
46
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
47.9
45
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.2
47.9
58
66
L03AA02
ATC
filgrastim; parenteral
506.0
46.3
45
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
18.3
45.9
38
23
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
45.8
43
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.4
43.5
56
69
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
42.5
40
*
A04AA02
ATC
granisetron; systemic, transdermal
430.1
39.9
39
*
Z51.5
ICD-10 Finland
Palliative care
8.9
39.7
53
68
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
39.3
37
*
GD1AD
NOMESCO Finland
Thorax CT examination
7.9
38.4
57
83
NG4AA
NOMESCO Finland
Lower leg X-ray examination
9.1
37.6
49
61
C40.00
ICD-10 Finland
Malignant tumor of the scapula and the long bones of the upper extremity without histology
+∞
36.0
34
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
198.4
35.4
36
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
34.9
33
*
L03AA13
ATC
pegfilgrastim; parenteral
192.3
34.3
35
*
WW500
NOMESCO Finland
Blood transfusion
12.3
34.0
35
31
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
32.8
31
*
115
Kela drug reimbursment
Breast cancer
+∞
31.7
30
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.7
31.3
86
224
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.1
31.0
59
111
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.3
30.7
95
271
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
30.6
29
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
29.6
28
*
B01AB05
ATC
enoxaparin; parenteral
3.4
29.4
158
653
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
315.0
29.2
29
*
B01AB10
ATC
tinzaparin; parenteral
5.3
29.0
65
142
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.8
28.6
42
60
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
28.5
27
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.6
28.0
48
81
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
10.5
28.0
32
33
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
27.4
26
*
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
27.4
26
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
26.4
222
1176
C40.90
ICD-10 Finland
Malignant tumor in unspecified locations in the bones of the extremities and articular cartilage without histology
+∞
26.4
25
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
26.0
126
483
WZC00
NOMESCO Finland
Treatment plan or consultation
3.1
25.3
160
717
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
25.3
24
*
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
24.2
23
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
24.2
23
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
24.2
23
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
29.0
24.0
32
12
R4110
NOMESCO Finland
Physiotherapy
3.1
23.9
141
604
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.2
23.8
37
56
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
23.2
22
*
WX402
NOMESCO Finland
General anaesthesia
3.4
23.0
106
391
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
25.8
22.5
31
13
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.6
22.5
46
92
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.1
22.2
28
33
C40.02
ICD-10 Finland
Chondrosarcoma of the scapula and long bones of the upper extremity
+∞
22.1
21
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
22.1
21
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
41.3
22.0
27
7
WF002
NOMESCO Finland
Radical radiotherapy
85.3
21.9
24
*
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
85.3
21.9
24
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.0
21.3
27
32
NB6AA
NOMESCO Finland
Humerus X-ray examination
8.6
21.2
28
35
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
21.0
20
*
C40.99
ICD-10 Finland
Malignant tumor in unspecified locations in the bones of the extremities and articular cartilage other or unspecified histology
+∞
20.0
19
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
77.5
19.9
22
*
N03AX14
ATC
levetiracetam; systemic
8.2
19.8
27
35
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.2
19.4
42
88
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
19.4
64
188
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.0
19.3
27
36
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
18.9
18
*
9101
FHL
Bone biopsy
+∞
18.9
18
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
18.9
18
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
18.9
18
*
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
73.8
18.9
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
105.4
18.7
20
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
199.5
18.7
19
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
199.5
18.7
19
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
17.1
90
353
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
17.0
154
800
C40.01
ICD-10 Finland
Osteosarcoma of the scapula and the long bones of the upper extremity
+∞
16.8
16
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
16.8
16
*
C40.10
ICD-10 Finland
Malignant tumor of the upper limb's short bones without histology
+∞
16.8
16
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
16.8
16
*
C40.91
ICD-10 Finland
Osteosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
16.8
16
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
6.1
16.1
29
51
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
16.1
139
702
ZXA05
NOMESCO Finland
Left side
2.7
15.9
117
547
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
15.7
15
*
ZX120
NOMESCO Finland
Intravenous
4.3
15.6
43
110
N03AX16
ATC
[U] pregabalin
2.7
15.0
103
463
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
14.9
87
359
HA1AA
NOMESCO Finland
X-ray mammography
6.5
14.9
25
41
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
14.8
60
201
JN4CD
NOMESCO Finland
Very extensive body CT
15.0
14.7
24
17
NK6AN
NOMESCO Finland
Total body bone isotope imaging
83.4
14.7
16
*
L01BC06
ATC
capecitabine; oral
+∞
14.7
14
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
14.7
14
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
155.8
14.6
15
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.1
14.5
26
23
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
4.9
14.3
33
73
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.1
14.0
25
22
L02BA01
ATC
tamoxifen; oral
55.5
13.9
16
*
NF3AD
NOMESCO Finland
Femur CT
55.5
13.9
16
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.1
13.8
30
63
L01AX03
ATC
temozolomide; systemic
+∞
13.6
13
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
13.6
13
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
13.6
13
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
13.6
13
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
145.0
13.5
14
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
145.0
13.5
14
*
A41.9
ICD-10 Finland
Sepsis, unspecified
5.6
13.4
26
49
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.6
13.4
22
35
9102
FHL
Trepanation or removal of the local bone process
41.7
13.3
16
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.4
13.0
50
161
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
51.9
12.9
15
*
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
14.7
12.9
21
15
N03AF02
ATC
oxcarbazepine; oral
5.4
12.9
26
51
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
12.8
42
122
1707A
ICD-9 Finland
Malignant neoplasm of bone and articular cartilage, Long bones of lower limb[ALARAAJAN PITKIEN LUIDEN SYÖPÄ,OSTEOSARCOMA]
+∞
12.6
12
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
12.6
12
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
12.6
12
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
12.5
154
890
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.0
12.1
36
97
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.2
12.0
33
84
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.8
11.8
22
40
D70.82
ICD-10 Finland
Drug-induced neutropenia
31.1
11.7
15
5
TPX15
NOMESCO Finland
Removal of vascular injection port
67.1
11.7
13
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.7
11.6
38
110
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
11.6
59
225
A04AD12
ATC
aprepitant; systemic
+∞
11.5
11
*
C40.93
ICD-10 Finland
Malignant tumor in unspecified locations in the bones and articular cartilage of the extremities
+∞
11.5
11
*
C40.11
ICD-10 Finland
Osteosarcoma of the short bones of the upper extremity
+∞
11.5
11
*
C40.0
ICD-10 Finland
Malignant neoplasm: Scapula and long bones of upper limb
+∞
11.5
11
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
11.5
11
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
11.5
11
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
11.5
11
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
11.5
11
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
A79
ICPC
Malignancy NOS
+∞
11.5
11
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
15.7
11.4
18
12
ZXE40
NOMESCO Finland
More than seven and less than nine hours
10.1
11.4
22
23
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
10.1
11.4
22
23
Z31.5
ICD-10 Finland
Genetic counselling
4.8
11.4
26
57
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
36.2
11.3
14
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
8.5
11.3
24
30
R4120
NOMESCO Finland
Occupational therapy
3.7
11.2
37
108
J04AB02
ATC
rifampicin; systemic
18.5
10.8
16
9
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
10.8
51
186
J01FF01
ATC
clindamycin; systemic
2.3
10.8
107
561
L02BG04
ATC
letrozole; oral
13.4
10.8
18
14
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.5
10.7
27
64
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.8
10.6
34
97
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
10.5
10
*
9180/3-C40.0
ICD-O-3
Osteosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.5
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
10.5
10
*
9220/3-C40.0
ICD-O-3
Chondrosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.5
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.5
10
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
10.5
10
*
NFB60
NOMESCO Finland
Demanding prosthetic replacement of hip
16.6
10.4
16
10
M05BX04
ATC
denosumab; parenteral
4.0
10.3
30
80
S18
ICPC
Laceration/cut
2.0
10.2
185
1216
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.7
10.2
24
54
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
20.7
9.9
14
7
ZXA00
NOMESCO Finland
Right side
2.2
9.8
110
602
2392A
ICD-9 Finland
Neoplasm of unspecified nature, Bone, soft tissue and skin
56.5
9.7
11
*
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
56.5
9.7
11
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.2
9.7
26
65
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.1
9.6
42
146
R50.9
ICD-10 Finland
Fever, unspecified
2.5
9.5
69
313
ZXE00
NOMESCO Finland
One hour or less
2.0
9.5
148
916
NG1AD
NOMESCO Finland
Knee CT examination
7.2
9.5
22
32
D16.1
ICD-10 Finland
Benign neoplasm: Short bones of upper limb
102.5
9.5
10
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
30.9
9.5
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
9.4
9
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
+∞
9.4
9
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
9.4
9
*
159
Kela drug reimbursment
Pazopanib
+∞
9.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
9.4
9
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
7.6
9.3
21
29
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
4.2
9.2
25
63
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.4
9.1
34
107
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
37.7
9.1
11
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
37.7
9.1
11
*
JN6AD
NOMESCO Finland
CT of torso and neck
19.2
9.0
13
7
B01AB04
ATC
dalteparin; parenteral
4.2
8.9
24
60
NF1AA
NOMESCO Finland
Hip X-ray examination
2.9
8.8
44
165
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
8.8
84
429
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
8.7
88
461
WZC30
NOMESCO Finland
Teaching
2.5
8.6
59
261
N02AX02
ATC
tramadol; systemic, rectal
1.9
8.5
163
1072
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
92.0
8.4
9
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
92.0
8.4
9
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
92.0
8.4
9
*
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
8.4
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
8.4
8
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
8.4
8
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
8.4
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.4
8
*
17041
ICD-8 Finland
Malignant neoplasm of bone, Long bones of upper limb and scapula
+∞
8.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
C40.12
ICD-10 Finland
Chondrosarcoma of the short bones of the upper extremity
+∞
8.4
8
*
Z89.6
ICD-10 Finland
Acquired absence of leg above knee
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
8.4
8
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
8.4
8
*
GDB10
NOMESCO Finland
Wedge resection of lung
+∞
8.4
8
*
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
34.1
8.1
10
*
Z3231
NOMESCO Finland
Registered nurse
2.0
8.1
110
642
XW000
NOMESCO Finland
Bone marrow biopsy
6.8
8.0
19
29
N02BE01
ATC
paracetamol; systemic, rectal
2.5
7.9
332
2820
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.9
7.9
39
146
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.0
7.8
22
57
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.5
7.8
19
44
ZZR00
NOMESCO Finland
Flap of skin
45.9
7.7
9
*
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
45.9
7.7
9
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
7.5
47
198
L28
ICPC
Limited function/disability (L)
2.1
7.5
84
455
ZXD05
NOMESCO Finland
Urgent procedure
1.9
7.4
116
707
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
81.6
7.4
8
*
M05BA02
ATC
clodronic acid; systemic
81.6
7.4
8
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
7.4
83
450
R4190
NOMESCO Finland
Nutritional therapy
4.0
7.4
21
55
C90.0
ICD-10 Finland
Multiple myeloma
+∞
7.3
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
C40.81
ICD-10 Finland
Overall osteosarcoma of the extremities' bones and articular cartilage
+∞
7.3
7
*
WW409
NOMESCO Finland
Other aferesis
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
C40.23
ICD-10 Finland
Ewing's sarcoma in the long bones of the lower extremity
+∞
7.3
7
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
C40.9
ICD-10 Finland
Malignant neoplasm: Bone and articular cartilage of limb, unspecified
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
7.3
7
*
C40.31
ICD-10 Finland
Osteosarcoma of the short bones of the lower extremity
+∞
7.3
7
*
C40.92
ICD-10 Finland
Chondrosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
NF3BD
NOMESCO Finland
Extensive femur CT
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
J01MA12
ATC
levofloxacin; systemic
2.1
7.3
73
379
XX2RW, ,
NOMESCO Finland
16.1
7.3
11
7
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
7.2
67
337
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
30.6
7.2
9
*
A06AH03
ATC
naloxegol; oral
20.5
7.2
10
5
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
5.8
7.2
19
34
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
10.3
7.1
13
13
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
6.5
7.0
17
27
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
14.1
6.9
11
8
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
6.9
101
601
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.4
6.8
15
21
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
10.3
6.6
12
12
N05BA06
ATC
lorazepam; systemic, sublingual
3.1
6.6
28
96
Z3226
NOMESCO Finland
Physiotherapist
2.1
6.6
74
401
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.5
6.5
18
34
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
6.5
26
86
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
71.0
6.4
7
*
D16.0
ICD-10 Finland
Benign neoplasm: Scapula and long bones of upper limb
71.0
6.4
7
*
NC2AA
NOMESCO Finland
Forearm X-ray examination
6.7
6.4
15
23
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
6.4
43
188
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
11.3
6.3
11
10
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
9.5
6.3
12
13
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
C41.4
ICD-10 Finland
Malignant neoplasm: Pelvic bones, sacrum and coccyx
+∞
6.3
6
*
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
6.3
6
*
C40.39
ICD-10 Finland
Malignant tumor of the lower extremity of the short bones or other unspecified histology
+∞
6.3
6
*
343
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
6.3
6
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
6.3
6
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
6.3
6
*
NGA10
NOMESCO Finland
Biopsy of soft tissue or joint of knee or lower leg, percutaneous
+∞
6.3
6
*
NGR40
NOMESCO Finland
Extensive excision of tumor of knee or lower leg with repair
+∞
6.3
6
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
6.3
6
*
X76
ICPC
Malignant neoplasm breast female
+∞
6.3
6
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
6.3
6
*
C40.89
ICD-10 Finland
Malignant overall tumor of the extremity bones and articular cartilage other or unspecified histology
+∞
6.3
6
*
2137A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Long bones of lower limb
+∞
6.3
6
*
C40.1
ICD-10 Finland
Malignant neoplasm: Short bones of upper limb
+∞
6.3
6
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
27.2
6.3
8
*
ZZR30
NOMESCO Finland
Flap of muscle
27.2
6.3
8
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
6.2
20
57
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
6.2
77
431
WX002
NOMESCO Finland
Sedation and analgesia
2.0
6.2
74
409
WX320
NOMESCO Finland
Spinalanesthesy
1.9
6.2
93
557
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
8.8
6.1
12
14
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
5.7
6.1
16
29
C03CA01
ATC
furosemide; systemic
1.8
6.0
115
740

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
65
70
11.01
56.18
1.7
1.3
—
—
—
0
0
118
421
3.62
27.43
12.6
3.7
0.79
0.83
mmol/l
1.85
111
401
184
881
3.13
26.07
4.3
2.1
—
—
—
0
0
178
900
2.85
21.91
3.0
1.6
—
—
—
0
0
227
1306
2.86
21.74
15.9
6.7
1.21
1.21
mmol/l
0.02
211
1199
243
1471
2.83
20.71
17.2
6.9
1.21
1.21
mmol/l
0.35
210
1298
144
670
2.86
20.48
5.3
2.1
—
—
—
0
0
260
1657
2.83
19.58
21.7
6.6
4.12
4.21
e9/l
0.19
235
1422
215
1247
2.69
19.55
9.5
4.2
34.48
36.14
g/l
3.79
203
1162
157
784
2.72
19.25
6.8
3.9
—
—
—
0
0
240
1485
2.70
18.89
14.8
3.9
9.18
12.00
umol/l
10.22
230
1413
70
224
3.61
18.66
1.4
1.1
—
—
—
0
0
90
341
3.15
18.28
9.3
9.1
0.92
1.11
mmol/l
0.21
76
287
177
960
2.59
18.08
8.3
2.0
2.36
2.35
mmol/l
0.10
167
831
90
351
3.05
17.32
9.3
8.9
7.41
7.42
ph
0.23
45
208
16
0
+∞
16.79
31.9
0.0
0.37
—
umol/l
—
16
0
212
1300
2.44
16.02
4.8
2.5
—
—
estimate
—
0
0
93
390
2.84
15.55
13.0
6.2
1.08
1.06
mmol/l
0.16
86
357
157
851
2.45
15.51
8.2
3.2
7.40
7.40
ph
0.34
120
601
50
144
3.85
15.44
4.0
1.5
54.18
2.60
ug/l
0.57
39
109
94
417
2.67
13.97
18.0
7.1
104.88
104.33
mmol/l
0.50
94
417
95
426
2.64
13.81
2.6
1.9
—
—
—
0
0
302
2257
2.70
13.70
15.8
5.5
87.11
78.16
u/l
1.48
290
2104
235
1588
2.27
13.14
9.9
5.7
1.67
1.87
e9/l
3.64
215
1390
211
1372
2.22
12.88
14.9
14.3
1.18
1.27
inr
1.89
175
1151
152
874
2.24
12.51
15.7
4.7
—
—
—
0
0
34
87
4.20
12.29
20.0
8.2
1.25
1.48
mg/l
1.19
34
76
228
1550
2.19
12.18
10.0
5.6
0.58
0.57
e9/l
0.15
206
1317
113
581
2.35
12.06
5.9
2.0
2.49
2.43
mmol/l
2.31
105
501
228
1560
2.17
11.86
10.1
5.6
0.03
0.04
e9/l
2.19
205
1328
163
981
2.17
11.81
11.8
5.6
—
—
—
0
0
68
278
2.76
11.72
19.7
8.3
1.10
1.37
mmol/l
2.25
68
273
69
287
2.72
11.49
15.9
8.5
—
—
—
0
0
30
77
4.15
10.79
7.6
1.3
47.94
31.29
mg/l
0.30
25
68
30
77
4.15
10.79
7.6
1.3
41.58
43.67
mg/l
0.05
25
67
249
1803
2.12
10.66
11.1
5.0
6.61
6.70
mmol/l
0.24
241
1706
230
1618
2.08
10.63
11.7
5.8
0.19
0.20
e9/l
0.44
210
1391
57
230
2.74
10.01
3.1
4.1
1.17
0.64
%
1.66
35
48
208
1450
1.97
9.42
9.8
5.7
25.07
27.96
%
3.22
203
1378
204
1415
1.96
9.35
10.0
5.7
2.67
3.03
%
1.36
198
1320
26
67
4.09
9.30
7.0
1.3
2.77
1.31
ratio
0.41
15
42
204
1417
1.96
9.29
10.2
5.8
9.16
8.82
%
1.01
198
1328
53
216
2.69
9.11
3.1
4.1
0.74
0.26
%
1.58
31
43
205
1439
1.93
8.92
9.9
5.7
58.75
57.21
%
1.10
200
1372
202
1419
1.91
8.69
10.2
5.8
0.63
0.68
%
0.74
196
1322
80
410
2.21
8.31
3.4
2.5
21.61
23.77
%
0.71
75
386
137
868
1.91
7.90
3.6
3.1
0.23
0.35
e6/l
1.19
104
619
15
16
9.71
7.85
2.1
3.8
—
—
—
0
0
41
159
2.77
7.74
5.3
1.4
—
—
—
0
0
51
222
2.50
7.65
3.0
4.2
0.07
0.11
%
0.22
29
38
152
1008
1.85
7.52
3.8
3.1
38.41
110.90
e6/l
0.55
120
754
70
361
2.15
7.10
2.5
1.7
—
—
—
0
0
20
53
3.93
6.90
1.5
1.5
—
—
—
0
0
51
233
2.37
6.89
2.6
2.7
0.20
0.21
g/l
0.59
51
214
190
1374
1.77
6.87
19.7
9.3
0.00
0.00
e9/l
0.86
161
1111
13
15
8.93
6.60
5.3
2.1
75.54
77.20
%
0.16
13
15
13
15
8.93
6.60
5.3
2.1
11.62
12.73
%
0.11
13
15
161
1130
1.74
6.31
4.9
3.8
39.07
98.95
e6/l
1.94
123
783
10
8
12.80
6.11
1.1
1.0
—
—
—
0
0
17
34
5.19
5.95
1.7
1.2
—
—
—
0
0
17
34
5.19
5.95
1.7
1.2
—
—
—
0
0
17
34
5.19
5.95
1.7
1.2
—
—
—
0
0
17
34
5.19
5.95
1.7
1.2
—
—
—
0
0
108
685
1.81
5.94
3.5
2.5
6.15
5.69
e6/l
0.14
101
616
10
9
11.37
5.82
2.1
1.3
3.24
4.46
mg/l
—
10
9
44
205
2.30
5.68
1.4
1.5
—
—
—
0
0
115
758
1.74
5.49
3.5
2.3
319.47
349.10
umol/l
2.11
105
672
11
14
8.05
5.38
4.0
1.1
0.59
0.81
e9/l
0.58
11
14
12
18
6.85
5.29
5.3
2.3
39.90
46.68
%
0.61
12
18
50
255
2.11
5.18
7.8
2.2
69.55
66.86
e9/l
0.23
42
193
92
583
1.76
4.98
4.0
2.7
540.96
551.26
mosm/kgh2o
0.20
85
500
15
41
3.77
4.97
2.9
3.2
4.65
4.41
e9/l
0.14
15
41
8
7
11.64
4.80
1.0
1.9
—
—
—
0
0
46
236
2.08
4.69
3.3
4.3
0.00
0.00
%
-0.00
23
34
126
888
1.63
4.55
3.6
3.1
—
—
—
0
0
59
335
1.90
4.53
4.5
2.5
4.98
7.51
umol/l
1.45
53
297
11
19
5.93
4.47
2.5
1.1
—
—
—
0
0
8
9
9.05
4.30
7.9
1.9
8.63
10.00
%
—
8
9
8
10
8.14
4.08
8.0
1.5
35.63
23.60
%
—
8
10
37
185
2.11
4.05
4.4
7.2
—
—
—
0
0
247
2078
1.55
3.88
5.2
4.3
—
4.09
—
0
6
113
803
1.58
3.85
2.6
2.3
3.15
2.75
mg/l
0.72
101
694
17
60
2.92
3.84
3.1
2.7
60.65
58.48
%
0.27
17
60
11
24
4.69
3.77
1.4
1.3
—
—
—
0
0
12
29
4.24
3.73
1.8
1.6
61.50
62.17
%
—
6
24
129
951
1.54
3.72
3.5
2.4
52.22
60.97
u/l
0.90
120
894
12
30
4.10
3.62
1.4
1.1
—
—
—
0
0
16
57
2.89
3.57
2.1
1.3
—
—
—
0
0
61
381
1.72
3.43
1.5
1.5
—
—
—
0
0
76
507
1.63
3.33
3.3
2.9
2.43
2.17
e6/l
0.12
36
232
155
1216
1.47
3.22
4.9
3.8
24.33
42.29
ng/l
1.85
124
844
10
24
4.25
3.21
2.4
1.7
334.90
1033.08
mg
—
10
24
16
61
2.69
3.17
3.3
4.4
—
—
—
0
0
9
20
4.58
3.13
1.2
1.1
—
—
—
0
0
13
41
3.25
3.09
3.1
1.3
—
—
—
0
0
56
352
1.69
3.07
1.8
1.5
—
—
—
0
0
33
176
1.96
3.07
23.5
4.2
0.70
0.63
%
0.81
33
176
336
3101
1.77
3.02
38.4
16.8
139.16
139.78
mmol/l
3.60
330
3040
14
51
2.81
3.02
1.6
1.4
—
—
—
0
0
196
1622
1.43
3.00
4.9
3.7
0.00
0.00
estimate
-0.00
44
321
60
387
1.65
2.99
4.4
2.6
3.55
4.57
e9/l
2.81
54
337
5
5
10.11
2.98
2.0
1.0
—
—
—
0
0
336
3104
1.76
2.97
38.8
16.8
3.94
3.98
mmol/l
1.84
329
3037
57
365
1.66
2.92
22.8
4.4
7.39
7.38
ph
0.42
31
219
42
247
1.79
2.91
2.6
2.3
0.85
0.28
e6/l
0.80
42
232
163
1310
1.43
2.90
4.0
3.3
6.42
6.21
ph
1.48
92
729
197
1639
1.42
2.89
4.9
3.7
0.00
0.02
estimate
0.65
42
305
18
77
2.40
2.86
1.6
1.5
13893.67
14131.52
e6/l
0.01
12
54
193
1604
1.42
2.83
4.9
3.7
0.00
0.00
estimate
-0.00
43
315
55
354
1.65
2.77
23.3
4.4
1.66
1.87
mmol/l
0.18
50
301
7
14
5.07
2.74
2.0
2.0
0.43
0.93
index
—
7
14
10
29
3.51
2.71
1.2
1.2
29.42
24.75
g/l
—
10
22
10
29
3.51
2.71
2.0
1.6
14.53
23.54
ng/l
—
10
29
39
230
1.78
2.68
8.8
5.0
7.42
7.41
ph
0.82
33
182
23
113
2.10
2.68
6.6
2.2
20.65
20.54
s
0.05
23
103
14
55
2.61
2.64
1.9
1.3
101.83
150.35
au/ml
—
6
21
32
179
1.86
2.61
24.2
4.3
1.34
1.19
%
0.58
32
179
7
15
4.73
2.61
1.3
1.0
1865.14
1721.93
miu/ml
—
7
15
15
62
2.48
2.57
1.6
1.3
258.60
183.93
u/ml
—
10
27
5
7
7.22
2.55
1.2
2.7
26.40
22.86
%
—
5
7
5
7
7.22
2.55
1.2
2.7
8.60
4.86
%
—
5
7
113
869
1.43
2.50
5.8
3.6
0.00
0.00
estimate
-0.00
41
297
7
16
4.44
2.48
1.3
1.1
—
—
—
0
0
285
2570
1.45
2.44
36.5
16.7
14.08
13.47
%
7.70
285
2536
66
459
1.53
2.41
1.7
1.6
—
—
—
0
0
6
12
5.06
2.41
1.2
2.0
155.17
156.83
e6/l
—
6
12
19
91
2.15
2.37
2.1
1.8
14.69
6.96
u/l
0.91
11
75
7
17
4.17
2.37
1.0
1.4
—
—
—
0
0
44
279
1.65
2.36
2.4
2.1
40.18
34.07
u/l
0.38
39
221
90
672
1.45
2.32
7.5
4.1
—
—
—
0
0
9
28
3.27
2.32
2.1
1.3
29.33
32.54
pg
—
9
28
8
23
3.53
2.28
1.3
1.2
—
—
—
0
0
9
29
3.15
2.24
2.1
3.4
—
—
—
0
0
121
968
1.37
2.08
5.5
3.3
1798.59
1255.81
ng/l
0.46
106
823
326
3047
1.52
2.05
32.0
13.5
29.19
23.18
mg/l
2.14
296
2401
6
15
4.05
2.04
1.0
1.1
—
—
—
0
0
13
57
2.33
2.00
3.8
3.9
2.78
2.90
mmol/l
—
6
35
5
11
4.59
1.94
1.4
1.1
7.50
7.33
ph
—
5
6
89
688
1.38
1.87
3.8
1.7
1.63
1.13
mg/l
0.94
71
515
6
17
3.57
1.84
1.0
1.1
—
—
—
0
0
5
12
4.21
1.83
3.6
3.9
821.80
612.42
u/ml
—
5
12
103
821
1.35
1.79
1.6
1.4
—
—
—
0
0
262
2383
1.33
1.74
4.8
4.1
14.77
14.83
pmol/l
0.12
245
2182
5
13
3.88
1.72
2.8
2.7
—
—
—
0
0
163
1396
1.30
1.69
2.7
2.6
79.01
77.40
nmol/l
0.28
146
1259
35
230
1.58
1.67
6.2
3.1
—
—
—
0
0
8
31
2.61
1.67
1.9
1.3
0.93
0.88
%
—
8
21
6
19
3.19
1.66
1.2
1.1
—
—
—
0
0
20
336
0.57
1.65
1.5
1.6
—
—
—
0
0
37
247
1.55
1.65
10.0
3.7
7.38
7.36
ph
0.58
26
171
146
1236
1.30
1.64
5.3
3.6
0.00
0.01
estimate
0.50
39
258
15
77
1.99
1.61
1.7
1.2
205.70
330.32
ug/g
—
10
42
8
33
2.45
1.54
69.6
10.1
9.26
11.83
%
—
8
33
113
1339
0.78
1.44
1.9
1.9
1.26
1.33
mmol/l
0.38
98
1143
6
22
2.75
1.44
1.7
1.7
16.92
17.17
%
—
6
22
5
120
0.41
1.40
1.2
1.1
—
—
—
0
0
122
1028
1.28
1.39
4.9
4.0
1.88
1.88
ug/l
0.00
113
913
6
23
2.63
1.37
1.2
1.3
—
—
—
0
0
25
160
1.60
1.35
11.8
5.7
—
—
—
0
0
18
293
0.59
1.35
1.3
1.3
—
—
—
0
0
10
47
2.16
1.35
6.0
4.3
10.52
11.82
pmol/l
—
10
47
118
995
1.27
1.33
3.3
2.2
351.56
289.40
u/l
0.18
112
943
5
18
2.80
1.29
1.6
1.2
166.80
168.87
mmol/24h
—
5
18
8
35
2.31
1.27
2.4
1.7
3.15
110.47
u/ml
—
8
35
18
110
1.67
1.17
2.2
1.7
28.18
21.66
iu/l
0.30
12
92
110
933
1.25
1.17
1.8
1.6
19.25
20.21
nmol/l
0.30
98
806
5
20
2.52
1.15
1.4
1.1
—
—
—
0
0
0
36
0.00
1.14
0.0
1.1
—
—
—
0
0
15
88
1.73
1.13
1.4
1.1
—
—
—
0
0
24
160
1.53
1.12
1.2
1.3
—
—
—
0
0
46
595
0.74
1.10
1.6
1.3
66.71
34.94
iu/ml
0.30
19
177
79
652
1.27
1.06
3.2
4.2
45.24
416.76
ng/l
2.47
67
519
163
1456
1.21
1.05
3.8
3.0
187.10
105.78
ug/l
2.72
155
1363
5
22
2.29
1.03
1.4
1.6
11.48
8.45
mmol/l
—
5
22
40
301
1.37
1.02
1.5
1.4
—
—
—
0
0
35
258
1.39
1.01
1.8
1.8
0.00
0.05
estimate
—
6
60
0
29
0.00
0.98
0.0
1.2
—
179.44
—
0
29
0
29
0.00
0.98
0.0
1.2
—
10.52
—
0
5
0
31
0.00
0.97
0.0
1.3
—
—
—
0
0
6
120
0.49
0.95
3.7
1.6
—
—
—
0
0
43
547
0.76
0.93
1.3
1.3
4.91
9.21
u/ml
0.51
17
214
6
28
2.16
0.92
1.0
1.2
—
—
—
0
0
6
28
2.16
0.92
1.5
2.9
—
—
—
0
0
5
101
0.49
0.91
1.0
1.1
—
0.59
—
0
12
287
3002
0.82
0.90
5.0
5.1
4.51
4.56
mmol/l
0.29
265
2809
11
64
1.74
0.87
3.4
1.7
—
—
—
0
0
297
2841
1.21
0.80
5.6
5.1
1.98
1.89
mu/l
0.54
278
2623
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
13
82
1.61
0.79
4.0
3.6
—
—
—
0
0
0
28
0.00
0.76
0.0
1.0
—
295.40
—
0
20
9
53
1.71
0.76
1.1
1.1
—
—
—
0
0
9
53
1.71
0.76
1.1
1.1
—
—
—
0
0
17
116
1.49
0.75
1.6
1.3
—
—
—
0
0
272
2844
0.84
0.75
6.5
6.5
39.32
39.48
mmol/mol
0.10
251
2681
6
110
0.54
0.73
1.0
1.1
1.45
1.53
g/l
—
6
110
287
2983
0.84
0.71
4.9
5.0
1.43
1.45
mmol/l
0.34
265
2773
327
3169
1.24
0.70
24.9
12.0
—
—
—
0
0
7
42
1.68
0.68
3.6
2.5
1.20
1.20
mmol/l
—
7
42
5
27
1.86
0.68
1.8
1.2
107.60
99.96
pmol/l
—
5
27
294
3047
0.84
0.68
5.4
5.8
2.63
2.67
mmol/l
0.38
271
2841
7
43
1.64
0.67
1.0
1.3
—
112.54
—
0
5
105
1171
0.86
0.66
3.1
3.2
—
—
—
0
0
7
44
1.60
0.65
7.4
1.1
19.46
17.37
u/l
—
7
38
7
44
1.60
0.65
3.6
2.4
4.01
4.10
mmol/l
—
7
44
7
44
1.60
0.65
3.6
2.4
105.14
105.82
mmol/l
—
7
44
12
79
1.54
0.63
3.7
1.8
—
—
—
0
0
330
3210
1.22
0.62
21.7
9.7
27.87
25.97
u/l
0.75
322
3110
272
2828
0.86
0.61
4.4
4.3
1.27
1.26
mmol/l
0.05
248
2613
7
113
0.61
0.59
1.7
1.1
0.90
0.90
g/l
—
7
113
6
36
1.68
0.57
1.0
1.1
—
—
—
0
0
6
37
1.63
0.56
1.2
1.2
1.69
1.36
nmol/l
—
6
32
25
316
0.78
0.55
1.9
1.8
—
—
—
0
0
11
74
1.50
0.54
1.1
1.2
—
—
—
0
0
6
39
1.55
0.53
1.0
1.3
0.58
0.64
nmol/l
—
6
34
216
2057
1.12
0.47
3.9
3.2
51.89
43.08
u/l
1.27
206
1942
13
94
1.40
0.46
1.3
1.3
—
2.82
—
0
16
64
566
1.16
0.46
1.8
2.0
—
—
—
0
0
84
764
1.13
0.41
5.4
3.7
1.02
1.02
kg/l
0.08
58
496
12
160
0.74
0.40
1.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.4
1.6
91.26
90.77
%
—
5
34
5
34
1.48
0.40
1.0
1.2
—
—
—
0
0
5
35
1.43
0.39
2.0
2.4
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
6.77
—
0
19
5
37
1.36
0.37
3.8
2.2
—
—
—
0
0
23
276
0.82
0.35
1.2
1.2
—
—
—
0
0
6
43
1.40
0.35
6.7
3.0
—
—
—
0
0
287
2938
0.90
0.34
5.0
4.9
5.90
5.95
mmol/l
0.22
260
2693
12
155
0.77
0.34
2.2
1.5
—
—
—
0
0
57
515
1.13
0.32
2.1
1.8
1339.93
1197.02
nmol/l
0.62
44
403
20
165
1.22
0.32
1.9
2.4
—
—
—
0
0
13
164
0.79
0.31
2.7
1.5
—
—
—
0
0
10
75
1.34
0.30
1.0
1.5
0.82
0.81
nmol/l
—
10
63
13
163
0.79
0.30
2.1
1.5
—
—
—
0
0
32
361
0.88
0.26
1.5
1.6
—
—
—
0
0
147
1407
1.07
0.25
2.0
2.1
94.24
95.72
pmol/l
0.13
80
726
16
133
1.21
0.24
1.6
1.7
—
—
—
0
0
5
39
1.29
0.23
1.4
1.2
—
—
—
0
0
5
40
1.25
0.22
1.4
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.68
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
43.92
—
0
10
0
12
0.00
0.21
0.0
1.0
—
13.15
—
0
7
44
403
1.10
0.21
1.1
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
104
1090
0.94
0.20
4.3
4.1
6.34
5.88
mg/mmol
0.06
71
688
0
14
0.00
0.20
0.0
1.2
—
21.33
—
0
6
95
904
1.07
0.19
4.9
3.1
0.00
0.00
estimate
-0.00
32
252
14
164
0.85
0.18
2.0
1.5
—
—
—
0
0
14
163
0.85
0.17
2.0
1.5
—
—
—
0
0
13
111
1.18
0.16
1.1
1.2
—
—
—
0
0
8
73
1.10
0.16
1.0
1.2
—
—
—
0
0
20
224
0.89
0.16
1.1
1.2
—
—
—
0
0
68
647
1.06
0.14
2.3
1.7
429.25
21429004.19
pmol/l
0.50
56
546
11
127
0.86
0.12
2.3
1.6
—
—
—
0
0
15
133
1.13
0.12
1.9
1.9
—
—
—
0
0
22
240
0.91
0.11
4.4
2.5
5.97
6.02
ph
0.07
15
159
46
438
1.06
0.10
1.2
1.4
400.00
502.18
titre
—
7
101
61
587
1.05
0.09
3.0
2.7
0.78
0.74
ug/l
0.14
44
362
338
3360
1.06
0.09
48.0
20.4
6.76
6.69
e9/l
0.23
333
3285
338
3360
1.06
0.09
48.0
20.3
4.31
4.56
e12/l
13.52
333
3284
338
3360
1.06
0.09
48.0
20.3
247.01
247.40
e9/l
0.04
333
3293
6
58
1.04
0.08
3.0
3.7
0.83
0.83
nmol/l
—
6
47
81
788
1.04
0.07
1.2
1.5
0.93
1.70
u/ml
1.15
24
223
71
690
1.04
0.07
2.5
1.4
2.31
2.45
g/l
0.14
56
425
9
86
1.05
0.07
1.0
1.2
1.89
10.72
e6/l
—
9
67
9
87
1.04
0.07
1.0
1.3
76.78
1400.81
e6/l
—
9
70
9
104
0.86
0.06
5.4
7.5
—
—
—
0
0
11
100
1.10
0.05
1.1
1.2
—
—
—
0
0
29
301
0.96
0.04
1.3
1.4
—
—
—
0
0
12
121
0.99
0.00
1.1
1.3
—
—
—
0
0
16
161
0.99
0.00
1.2
1.2
—
14.20
—
0
5
10
103
0.97
0.00
1.6
1.5
0.18
0.22
g/l
—
10
98
118
1177
1.00
0.00
3.8
3.4
7.48
7.76
mmol/l
0.29
101
1012
106
1065
0.99
0.00
3.5
3.4
82.37
37.60
mg/l
0.41
73
695
10
104
0.96
0.00
1.5
1.5
1.12
1.16
g/l
—
10
98
0
8
0.00
0.00
0.0
7.0
—
7.95
—
0
8
0
8
0.00
0.00
0.0
8.3
—
4.76
—
0
8
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
8
85
0.94
-0.00
1.4
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
74.67
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.05
—
0
5
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
98
0.92
-0.00
1.0
1.7
230.44
313.37
mu/l
—
9
89
0
9
0.00
-0.00
0.0
1.8
—
0.50
—
0
9
7
75
0.93
-0.00
4.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
8.2
—
25.44
—
0
9
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
57.20
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
2.00
—
0
6

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: C3_BONE_CARTILAGE_LIMBS_WIDE – Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).